MAPT and Alzheimer disease: Clinically, AD manifests as progressive memory impairment, accompanied by cognitive dysfunction and personality changes, with pathological hallmarks including senile plaques formed by the aggregation of pathogenic amyloid-β (Aβ) protein, neurofibrillary tangles composed of hyperphosphorylated tau within neurons, and neuronal loss [3].